That's a great question. It's exactly the question that we asked the project teams who gave us proposals for the personalized health competition. They had to indicate what the economic rationale was for introducing the genomics-based—whatever in particular it was—in cancer or epilepsy or whatever. What is the economic value to the health system? If they did not have a business case, that proposal went in the bin. We were only going to entertain those that demonstrated economic sustainability value to the health system.
On March 5th, 2013. See this statement in context.